InsiderTrades.com logo

URGN Insider Trading

Insider Ownership Percentage: 4.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $923,179.64

Urogen Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Urogen Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Urogen Pharma Share Price & Price History

Current Price: $24.28
Price Change: ▼ Price Decrease of -0.07 (-0.29%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for URGN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Urogen Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2025Mark SchoenbergInsiderSell10,000$25.00$250,000.00139,025View SEC Filing Icon  
10/8/2025Chris DegnanCFOSell2,203$16.85$37,120.552,280View SEC Filing Icon  
9/8/2025Jason Drew SmithGeneral CounselSell1,520$19.11$29,047.2043,305View SEC Filing Icon  
9/8/2025Mark SchoenbergInsiderSell871$19.11$16,644.81149,025View SEC Filing Icon  
8/11/2025Mark SchoenbergInsiderSell10,000$17.69$176,900.00148,229View SEC Filing Icon  
7/28/2025Jason Drew SmithGeneral CounselSell7,522$19.14$143,971.0841,492View SEC Filing Icon  
7/28/2025Mark SchoenbergInsiderSell5,149$19.14$98,551.86158,229View SEC Filing Icon  
6/9/2025Mark SchoenbergInsiderSell5,162$7.37$38,043.94153,378View SEC Filing Icon  
1/31/2025Jason Drew SmithGeneral CounselSell7,379$11.14$82,202.0626,468View SEC Filing Icon  
1/31/2025Mark SchoenbergInsiderSell4,551$11.14$50,698.14145,666View SEC Filing Icon  
9/9/2024Jason Drew SmithGeneral CounselSell1,521$13.08$19,894.6825,226View SEC Filing Icon  
9/9/2024Mark SchoenbergInsiderSell859$13.08$11,235.72145,091View SEC Filing Icon  
6/10/2024Mark SchoenbergInsiderSell5,153$13.08$67,401.24144,284View SEC Filing Icon  
3/18/2024Mark SchoenbergInsiderSell12,000$14.05$168,600.00139,437View SEC Filing Icon  
1/31/2024Jason Drew SmithGeneral CounselSell4,993$15.74$78,589.8218,824View SEC Filing Icon  
1/31/2024Mark SchoenbergInsiderSell3,789$15.74$59,638.86149,423View SEC Filing Icon  
8/31/2023Jason Drew SmithGeneral CounselSell3,800$18.01$68,438.0018,407View SEC Filing Icon  
1/31/2023Jason Drew SmithGeneral CounselSell1,636$10.12$16,556.3212,600View SEC Filing Icon  
1/31/2023Mark SchoenbergInsiderSell1,900$10.12$19,228.00146,879View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Urogen Pharma (NASDAQ:URGN)

91.29% of Urogen Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at URGN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Urogen Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Jacobs Levy Equity Management Inc.21,376$0.43M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/17/2025TCG Crossover Management LLC717,347$14.31M0.7%N/A1.532%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd29,302$0.59M0.0%N/A0.063%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC687,475$13.72M0.0%N/A1.469%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC89,028$1.78M0.0%N/A0.190%Search for SEC Filing on Google Icon
11/17/2025Paradigm Biocapital Advisors LP4,216,084$84.11M2.4%N/A9.007%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC402,595$8.03M0.8%+127.8%0.860%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,017$0.34M0.0%-15.8%0.036%Search for SEC Filing on Google Icon
11/17/2025HighVista Strategies LLC31,886$0.64M0.2%N/A0.068%Search for SEC Filing on Google Icon
11/17/2025Farallon Capital Management LLC11,000$0.22M0.0%N/A0.023%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE108,454$2.16M0.0%-59.1%0.232%Search for SEC Filing on Google Icon
11/14/2025Creative Planning10,444$0.21M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC297,851$5.94M0.0%+36.3%0.636%Search for SEC Filing on Google Icon
11/14/2025Man Group plc10,780$0.22M0.0%-24.5%0.023%Search for SEC Filing on Google Icon
11/14/2025Orbimed Advisors LLC689,000$13.75M0.3%+44.0%1.472%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP386,203$7.71M0.0%+103.9%0.825%Search for SEC Filing on Google Icon
11/13/2025Jump Financial LLC103,866$2.07M0.0%N/A0.222%Search for SEC Filing on Google Icon
11/13/2025Annandale Capital LLC70,552$1.41M0.2%-6.6%0.151%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG180,460$3.60M0.0%-41.5%0.386%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets308,328$6.15M0.0%+328.7%0.659%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.3,321$66K0.0%+1,594.4%0.007%Search for SEC Filing on Google Icon
11/13/2025Jefferies Financial Group Inc.2,199,652$43.88M0.2%-1.3%4.699%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC55,619$1.11M0.0%-20.7%0.119%Search for SEC Filing on Google Icon
11/12/2025Orion Porfolio Solutions LLC11,008$0.22M0.0%N/A0.024%Search for SEC Filing on Google Icon
11/12/2025HAP Trading LLC19,806$0.27M0.0%N/A0.042%Search for SEC Filing on Google Icon
11/12/2025ARK Investment Management LLC126,720$2.53M0.0%-23.7%0.271%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC15,227$0.30M0.0%-19.4%0.033%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.16,902$0.34M0.1%N/A0.036%Search for SEC Filing on Google Icon
11/10/2025TD Asset Management Inc44,000$0.88M0.0%-17.6%0.094%Search for SEC Filing on Google Icon
11/10/2025Ameritas Investment Partners Inc.3,082$61K0.0%-19.6%0.007%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.8,109$0.16M0.0%-12.4%0.017%Search for SEC Filing on Google Icon
11/10/2025Persistent Asset Partners Ltd20,726$0.41M0.3%-40.1%0.044%Search for SEC Filing on Google Icon
11/7/2025NEOS Investment Management LLC50,458$1.01M0.0%N/A0.109%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP48,964$0.98M0.1%N/A0.106%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.303,785$6.06M0.0%+19.1%0.657%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.534,545$10.66M0.0%+36.9%1.156%Search for SEC Filing on Google Icon
11/4/2025Allianz Asset Management GmbH22,000$0.44M0.0%+48.6%0.048%Search for SEC Filing on Google Icon
11/4/2025State of Wyoming3,301$66K0.0%N/A0.007%Search for SEC Filing on Google Icon
11/4/2025Privium Fund Management B.V.196,622$3.92M0.7%+82.7%0.425%Search for SEC Filing on Google Icon
11/3/2025Truist Financial Corp72,286$1.44M0.0%+134.3%0.156%Search for SEC Filing on Google Icon
10/30/2025Strs Ohio3,800$76K0.0%N/A0.008%Search for SEC Filing on Google Icon
10/29/2025Oak Ridge Investments LLC87,507$1.75M0.1%+24.0%0.189%Search for SEC Filing on Google Icon
10/29/2025Harel Insurance Investments & Financial Services Ltd.82,772$1.65M0.0%-47.5%0.179%Search for SEC Filing on Google Icon
10/29/2025Meitav Investment House Ltd.31,513$0.63M0.0%-12.8%0.068%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC1,157,383$23.09M0.1%+0.7%2.502%Search for SEC Filing on Google Icon
10/22/2025Hennion & Walsh Asset Management Inc.65,183$1.30M0.0%+69.9%0.141%Search for SEC Filing on Google Icon
10/16/2025Rice Hall James & Associates LLC259,143$5.17M0.3%-10.0%0.560%Search for SEC Filing on Google Icon
10/15/2025CWM LLC4,271$85K0.0%+18.0%0.009%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC83,611$1.67M0.0%+38.6%0.181%Search for SEC Filing on Google Icon
9/4/2025Osaic Holdings Inc.3,695$50K0.0%+491.2%0.008%Search for SEC Filing on Google Icon
8/28/2025China Universal Asset Management Co. Ltd.9,261$0.13M0.0%+9.4%0.020%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC94,309$1.29M0.0%+187.8%0.204%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 6,891$94K0.0%+422.0%0.015%Search for SEC Filing on Google Icon
8/15/2025Soleus Capital Management L.P.2,185,000$29.93M2.0%N/A4.723%Search for SEC Filing on Google Icon
8/15/2025Man Group plc14,285$0.20M0.0%N/A0.031%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets71,921$0.99M0.0%+2,874.4%0.155%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE265,117$3.63M0.0%+34.7%0.573%Search for SEC Filing on Google Icon
8/15/2025Acorn Capital Advisors LLC1,259,749$17.26M11.3%-16.9%2.723%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.830,000$11.37M0.0%-35.0%1.794%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.30,880$0.42M0.0%-8.5%0.067%Search for SEC Filing on Google Icon
8/14/2025Orbimed Advisors LLC478,400$6.55M0.2%N/A1.034%Search for SEC Filing on Google Icon
8/14/2025Quantinno Capital Management LP21,073$0.29M0.0%N/A0.046%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.20,209$0.28M0.0%-13.3%0.044%Search for SEC Filing on Google Icon
8/14/2025Vivaldi Capital Management LP15,661$0.22M0.0%-22.2%0.034%Search for SEC Filing on Google Icon
8/14/2025Main Street Financial Solutions LLC25,968$0.36M0.0%+8.2%0.056%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 37,476$0.51M0.0%-1.8%0.081%Search for SEC Filing on Google Icon
8/14/2025Squarepoint Ops LLC94,309$1.29M0.0%+187.8%0.204%Search for SEC Filing on Google Icon
8/14/2025Nebula Research & Development LLC11,843$0.16M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/14/2025Diadema Partners LP150,000$2.06M0.6%+96.8%0.324%Search for SEC Filing on Google Icon
8/14/2025Menora Mivtachim Holdings LTD.1,152,531$15.79M0.1%-50.0%2.491%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP20,660$0.28M0.0%+79.7%0.045%Search for SEC Filing on Google Icon
8/13/2025Walleye Capital LLC346,162$4.74M0.0%N/A0.748%Search for SEC Filing on Google Icon
8/13/2025Panagora Asset Management Inc.261,785$3.59M0.0%+181.9%0.566%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers51,293$0.70M0.0%-4.1%0.111%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.390,364$5.35M0.0%+5.2%0.844%Search for SEC Filing on Google Icon
8/12/2025Entropy Technologies LP19,379$0.27M0.0%N/A0.042%Search for SEC Filing on Google Icon
8/11/2025Persistent Asset Partners Ltd34,600$0.47M0.4%+96.9%0.075%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC18,902$0.26M0.0%-28.3%0.041%Search for SEC Filing on Google Icon
8/8/2025Cetera Investment Advisers26,370$0.36M0.0%N/A0.057%Search for SEC Filing on Google Icon
8/8/2025SG Americas Securities LLC1,149,081$15.74M0.1%+607.1%2.487%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC470,726$6.45M0.0%-0.6%1.019%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC32,453$0.45M0.0%N/A0.070%Search for SEC Filing on Google Icon
8/5/2025Harel Insurance Investments & Financial Services Ltd.157,772$2.16M0.0%-57.8%0.341%Search for SEC Filing on Google Icon
8/4/2025Migdal Insurance & Financial Holdings Ltd.770,909$10.56M0.1%-2.0%1.666%Search for SEC Filing on Google Icon
7/30/2025ARK Investment Management LLC166,094$2.28M0.0%-10.6%0.360%Search for SEC Filing on Google Icon
7/28/2025Allianz Asset Management GmbH14,800$0.20M0.0%N/A0.032%Search for SEC Filing on Google Icon
7/25/2025CWM LLC3,621$50K0.0%-30.7%0.008%Search for SEC Filing on Google Icon
7/25/2025Oak Ridge Investments LLC70,570$0.97M0.1%-4.3%0.153%Search for SEC Filing on Google Icon
7/24/2025Bender Robert & Associates34,701$0.48M0.1%N/A0.075%Search for SEC Filing on Google Icon
7/18/2025Truist Financial Corp30,850$0.42M0.0%N/A0.067%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.284,334$3.15M0.0%-10.5%0.617%Search for SEC Filing on Google Icon
6/18/2025Voya Investment Management LLC10,092$0.11M0.0%-10.3%0.022%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC51,177$0.57M0.0%+94.3%0.111%Search for SEC Filing on Google Icon
5/19/2025UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC4,360,524$48.23M0.0%+216.6%9.457%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.284,334$3.15M0.0%-10.5%0.617%Search for SEC Filing on Google Icon
5/16/2025Parkman Healthcare Partners LLC393,153$4.35M0.5%+6.3%0.853%Search for SEC Filing on Google Icon
5/16/2025Millennium Management LLC423,585$4.69M0.0%-34.4%0.919%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.23,320$0.26M0.0%+7.6%0.051%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC114,066$1.26M0.0%+347.5%0.247%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.1,277,000$14.12M0.0%-56.4%2.770%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Urogen Pharma logo
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301 for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; strategic research collaboration agreement with MD Anderson focusing on the sequential use of UGN-201 and UGN-301 for the treatment of NMIBC; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 in low-grade intermediate risk NMIBC and UGN-104 in low-grade upper tract urothelial carcinoma. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Read More on Urogen Pharma

Today's Range

Now: $24.28
Low: $23.92
High: $24.92

50 Day Range

MA: $21.26
Low: $16.42
High: $29.42

52 Week Range

Now: $24.28
Low: $3.42
High: $30.00

Volume

715,555 shs

Average Volume

1,298,451 shs

Market Capitalization

$1.14 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.21

Who are the company insiders with the largest holdings of Urogen Pharma?

Urogen Pharma's top insider investors include:
  1. Mark Schoenberg (Insider)
  2. Jason Drew Smith (General Counsel)
  3. Chris Degnan (CFO)
Learn More about top insider investors at Urogen Pharma.

Who are the major institutional investors of Urogen Pharma?

Urogen Pharma's top institutional investors include:
  1. Paradigm Biocapital Advisors LP — 9.01%
  2. Jefferies Financial Group Inc. — 4.70%
  3. SG Americas Securities LLC — 2.50%
  4. TCG Crossover Management LLC — 1.53%
  5. Orbimed Advisors LLC — 1.47%
  6. Voloridge Investment Management LLC — 1.47%
Learn More about top institutional investors of Urogen Pharma stock.

Which institutional investors are selling Urogen Pharma stock?

In the last quarter, URGN stock was sold by these institutional investors:
  1. Citadel Advisors LLC
  2. Bank of America Corp DE
  3. Susquehanna International Group LLP
  4. UBS Group AG
  5. Group One Trading LLC
  6. Harel Insurance Investments & Financial Services Ltd.
  7. ARK Investment Management LLC
  8. Jefferies Financial Group Inc.
Within the previous year, company insiders that have sold Urogen Pharma company stock include:
  1. Mark Schoenberg (Insider)
  2. Jason Drew Smith (General Counsel)
  3. Chris Degnan (CFO)
Learn More investors selling Urogen Pharma stock.

Which institutional investors are buying Urogen Pharma stock?

Within the last quarter, URGN stock was purchased by institutional investors including:
  1. Paradigm Biocapital Advisors LP
  2. TCG Crossover Management LLC
  3. Voloridge Investment Management LLC
  4. BNP Paribas Financial Markets
  5. Parkman Healthcare Partners LLC
  6. Orbimed Advisors LLC
  7. Two Sigma Investments LP
  8. JPMorgan Chase & Co.